We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Eases Trial Requirements for Drugs to Treat Alzheimer’s
FDA Eases Trial Requirements for Drugs to Treat Alzheimer’s
July 20, 2011
The FDA is broadening the allowed participant pool and relaxing MRI requirements for Alzheimer’s drug trials in response to recommendations from a stakeholder working group.